Agenus
AGEN
#8981
Rank
NZ$0.26 B
Marketcap
NZ$6.77
Share price
-9.50%
Change (1 day)
75.93%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): NZ$35.28 Million

According to Agenus 's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2024 the company made an earning of -NZ$0.2 Billion, an increase over its 2023 earnings that were of -NZ$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$35.28 M-118.18%
2024 -NZ$0.2 Billion-28.13%
2023 -NZ$0.28 Billion-5.5%
2022 -NZ$0.29 Billion-556.26%
2021 NZ$62.64 M-130.37%
2020 -NZ$0.21 Billion73.75%
2019 -NZ$0.12 Billion-48.74%
2018 -NZ$0.24 Billion34.32%
2017 -NZ$0.18 Billion-7.16%
2016 -NZ$0.19 Billion26.55%
2015 -NZ$0.15 Billion110.24%
2014 -NZ$69.81 Million49.12%
2013 -NZ$46.82 Million
2011 -NZ$32.32 Million-12.25%
2010 -NZ$36.84 Million-21.41%
2009 -NZ$46.87 Million-26.86%
2008 -NZ$64.09 Million13.72%
2007 -NZ$56.35 Million-33.4%
2006 -NZ$84.62 Million-31.84%
2005 -NZ$0.13 Billion9.74%
2004 -NZ$0.12 Billion-0.8%
2003 -NZ$0.12 Billion17.37%
2002 -NZ$97.16 Million37.83%
2001 -NZ$70.49 Million55.99%
2000 -NZ$45.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$56.81 B 162,277.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$37.96 B 108,417.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$15.79 B 45,043.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$16.75 B 47,791.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-NZ$0.49 Billion-1,490.73%๐Ÿ‡บ๐Ÿ‡ธ USA